Agency Archives - Page 14 of 21 - EverGlade

Agency

Transparent ampules on a blue background

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections

Leave a Comment / All Posts, BARDA, Life Sciences / By

Combating Resistant Infections: BARDA’s Push for Advanced Antibiotics The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a pre-solicitation notice aimed at identifying qualified vendors to support the late-stage development, procurement, and stockpiling of antibiotics for critical public health threats. Targeted programs include

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections Read More »

Vaccine Development

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines

Leave a Comment / BARDA, Life Sciences / By

Preparing for the Next Biological Threat: BARDA’s Vaccine Initiative for MARV and SUDV The Biomedical Advanced Research and Development Authority (BARDA), operating under the U.S. Department of Health and Human Services (HHS), has issued a pre-solicitation notice signaling its intent to launch a major Request for Proposal (RFP) later this year. This effort, managed by

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines Read More »

Digital illustration of the lymphatic system in the human body from chest up.

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity

Leave a Comment / Agency, CPE CBRND / By

The U.S. Army Contracting Command – New Jersey (ACC-NJ), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a new Request for Prototype Proposals (RPP-25-05) through the Medical CBRN Defense Consortium (MCDC). Administered by Advanced Technology International (ATI), this solicitation seeks novel approaches for enhancing the

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity Read More »

Viral pathogen coronavirus

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats

Leave a Comment / Agency, All Posts, CPE CBRND / By

The U.S. Department of Defense (DoD), through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Prototype Proposals (RPP-25-06) under the Medical CBRN Defense Consortium (MCDC) under OTA W15QKN-16-9-1002. This new initiative, Operationalizing Novel Technologies for Advanced Rapid Generation of Effective Medical Countermeasures (ONTARGET), is looking

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats Read More »

3d rendered image of highly pathogenic avian influenza

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA), has issued a new Request for Prototype Proposals (RPP) through the Medical CBRN Defense Consortium (MCDC). “Increased Micro Sampling to Monitor Immunological Response” (IMMIR) seeks to improve our ability to monitor immune responses to vaccination, which is critical for accelerating vaccine

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP Read More »

digital rendering of antigens

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA), has released a new Request for Prototype Proposals (RPP-25-07) under the Medical CBRN Defense Consortium (MCDC). This Request for Project Proposals, titled “Defined Rapid Antigen Identification and Immunogenic Characterization” (DRAIIC), aims to increase protection against infectious

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP Read More »

Medicine manufacturing assembly line.

ARPA-H’s Scalable Solutions ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Mission Office Innovative Solutions Opening (ISO)– ARPA-H-SOL-24-105 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) officially released solicitation ARPA-H-SOL-24-105 under its Scalable Solutions Office (SSO), titled Mission Office Innovative Solutions Opening (ISO). This initiative aims to fuel bold, high-impact biomedical and health innovations that tackle persistent barriers in health

ARPA-H’s Scalable Solutions ISO Read More »

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

Leave a Comment / DARPA, Emerging Technologies / By

Special Topic: Ag x BTO To defend against threats to America’s agricultural infrastructure, the Defense Advanced Research Projects Agency (DARPA) has launched a new Special Topic Area (STA) through its Biological Technologies Office (BTO). Known as Ag x BTO, this initiative seeks to catalyze innovative approaches to defending the U.S. agricultural system from chemical, biological,

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations Read More »

Doctor holding augmented reality medical-related digital icons

ARPA-H Resilient Systems ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RESILIENT SYSTEMS OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-103 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Innovative Solutions Opening (ISO) under the Resilient Systems Office (RSO), under Solicitation Number ARPA-H-SOL-24-103. a mission-focused solicitation designed to confront systemic challenges across

ARPA-H Resilient Systems ISO Read More »

Digital composite image of scientific experiment and dNA strands

ARPA-H Health Science Futures ISO

Leave a Comment / ARPA-H, Life Sciences / By

Health Science Futures – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) ARPA-H-SOL-24-104 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO), under Solicitation Number ARPA-H-SOL-24-104. As part of its mission to catalyze high-risk, high-reward research,

ARPA-H Health Science Futures ISO Read More »

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

Leave a Comment / ARPA-H, Life Sciences / By

On June 6, 2025, the Advanced Research Projects Agency for Health (ARPA-H) issued Amendment 02 to its four flagship Innovation Solutions Opening (ISO) solicitations: Health Science Futures (HSF), Proactive Health Office (PHO), Resilient Systems Office (RSO), and Scalable Solutions Office (SSO). These ISOs represent the core operational arms of ARPA-H’s mission to fund transformative, high-risk,

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments Read More »

Vaccine Research

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA

Leave a Comment / BARDA, Life Sciences / By

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA BAA-23-100-SOL-00004 – Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) In response to today’s evolving public health landscape, the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS) within the Administration for Strategic

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA Read More »

Scroll to Top